SK hynix unveils its next-gen technology roadmap: includes HBM5, HBM5E, GDDR7-Next, DDR6, and 400+ layer NAND memory beyond 2029-2031.
D Molecular Therapeutics (4DMT) has announced an exclusive licence agreement with Otsuka Pharmaceutical to develop and market 4D-150.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果